The IMPRS-EBM PhD 2027 call opens on 18 December 2026, offering fully funded doctoral positions in epigenetics, biophysics and metabolism at the Max Planck Institute of Immunobiology and Epigenetics and the University of Freiburg. The International Max Planck Research School for Epigenetics, Biophysics and Metabolism trains researchers across molecular biology, biochemistry, biophysics and computation, including AI and machine learning. Applications close on 5 February 2027, with references due by 9 February 2027.
| Programme | IMPRS-EBM PhD 2027 — International Max Planck Research School for Epigenetics, Biophysics and Metabolism |
| Host | Max Planck Institute of Immunobiology and Epigenetics and University of Freiburg |
| Funding | Fully funded — employment contract for the PhD, health and retirement insurance, 30 vacation days/year, no tuition fees (no salary figure stated) |
| Duration | PhD programme; employment contract for the duration of the PhD |
| Start | Onboarding September 2027; start in thesis lab October 2027 |
| Deadline | 5 February 2027 (references by 9 February 2027) |
| Status | Verified |
Why IMPRS-EBM matters for Indian researchers
IMPRS-EBM is built for researchers who do not fit neatly into one discipline. The programme integrates molecular biology and biochemistry with biophysical and computational methods, and it leverages AI and machine learning in its research — so a candidate with a background in biology, biochemistry, bioinformatics, biophysics, chemistry, physics or computational biology can find a lab. Research fields span epigenetics, biophysics, metabolism, cell biology, biochemistry, proteomics, bioinformatics and functional genomics, with mentoring by the group leader and a Thesis Advisory Committee and access to world-class core facilities.
For Indian applicants, the practical points are strong. There is no application fee, applications are open to all nationalities, and the funding is an employment contract for the PhD — including health and retirement insurance, 30 vacation days a year on top of public holidays, and no tuition fees. English is the programme’s official language and German is not required; successful applicants get a free German course. Freiburg is a vibrant university city and the gateway to the Black Forest.
Eligibility
You must hold an MSc or Diploma in biology, biomedicine, biochemistry, bioinformatics, biophysics, chemistry, physics, computational biology or a related subject — the degree must be obtained before the start of the programme, although you can apply while you are still completing it. You need both a BSc and an MSc or equivalent — usually five years of university studies. An MD or DVM is not a substitute for an MSc, and a five-year BSc alone is not a substitute (a University of Freiburg requirement).
The programme expects an outstanding academic record — a GPA above 80%, a first or upper second class degree, or being in the top 10% of students in a given year — plus at least four to six months of practical lab experience and excellent English language skills. A TOEFL or IELTS certificate (or equivalent) is recommended, but not required, if you are not a native speaker or did not study in English. No GRE is required, though you may upload a score if you wish.
How to apply
Applications to IMPRS-EBM go through the online application tool only, open 18 December 2026 to 5 February 2027. You will need a two-page motivational letter, a CV, and your Bachelor’s and Master’s transcripts and certificates, each uploaded as a single PDF. You also list two referees, who complete a reference form and a reference letter; only applications with both references in by 9 February 2027 are considered. You can browse all current opportunities on IISER Connect and explore the PhD & Postdoc hub for similar funded doctorates.
In the form, select three to four faculty members, ranked by preference — not all faculty offer projects in every round. List any supervised research projects that lasted at least four weeks, and list only international, peer-reviewed publications. Your motivational letter should be in your own words, highlight your major experimental experience, and explain why you are interested in joining specific labs. You can stop and continue within 29 days via an emailed link — but once submitted, you cannot make changes, so submit early.
Deadline warning
The IMPRS-EBM deadline is 5 February 2027 for the complete application, and 9 February 2027 for your referees. The selection then runs in three stages: pre-selection video interviews on 10–19 March 2027, an online panel assessment in early April 2027, and onsite interviews in Freiburg on 7–10 June 2027. The strongest candidates receive offers at the end of the onsite interviews, to join their ideal lab directly; onboarding starts in September 2027 and lab research in October 2027. The window opens only on 18 December 2026, so prepare your motivational letter, transcripts and referee list now.
Sources checked
Official sources: Max Planck Institute of Immunobiology and Epigenetics — “IMPRS PhD program”, “How to apply”, “Requirements” and “Tips for the application” (ie-freiburg.mpg.de) — all verified 19 November 2026: Recruitment 2027 timeline, fully funded employment contract, no tuition fees, MSc/Diploma and BSc + MSc requirements, GPA above 80%, 4–6 months of lab experience, English requirements, documents and referees by 9 February 2027. Note: the programme overview lists the online panel as 5 & 6 April 2027 while the application pages list 2, 5, 6 April 2027 — confirm the exact date on the official pages. No salary figure is stated officially, so none is published here. Status: Verified.